Scipher Medicine is bringing personalized care to diseases that are currently managed by a one-size-fits-all approach by developing a battery of drug response tests aimed at enabling physicians to select optimal therapy based on an individual patient's biological signature.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
02/20/20 | undisclosed | Strategic |
Optum Ventures | undisclosed |
02/28/22 | $110,000,000 |
Alumni Ventures Group aMoon Cowen Healthcare Investments Echo Health Ventures Hitachi Ventures Laurion Capital Management Monashee Investment Management Neuberger Berman Northpond Ventures Optum Ventures | undisclosed |